Coronary heart disease is the leading cause of death in women in the United States and increases dramatically in postmenopausal women. The following review summarizes the known benefits and risks of hormone replacement therapy and gives recommendations for use of hormone replacement in women. Estrog
Hormone replacement therapy
β Scribed by Teake Kooistra; Jef J Emeis
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 655 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1367-5931
No coin nor oath required. For personal study only.
β¦ Synopsis
Hormone replacement therapy is increasingly being used for purposes unrelated to the alleviation of menopausal symptoms, such as the prevention of osteoporosis and cardiovascular disease. Clinical trials, however, suggest that the one drug/many purposes concept may be too optimistic. The availability of new estrogen-like compounds and the discovery of a second estrogen receptor have opened new possibilities for more specific drug development.
π SIMILAR VOLUMES
This study addresses the question of willingness to pay (WTP) for hormone replacement therapy (HRT) in order to alleviate menopausal symptoms. The woman obtains utility from consumption of goods and health. The purchase of a treatment is represented as a shift in the health production function durin
## Abstract The principal cause of death in postβmenopausal women with diabetes is cardiovascular disease. Women who use hormone replacement therapy (HRT) have been shown to have a 50% reduction in their risk of coronary heart disease (CHD). The aim of this study was to determine if general practit
## Abstract ## BACKGROUND. The association between hormone replacement therapy (HRT) and a reduced lung cancer risk has been reported in previous studies. There is a high female to male ratio in Chinese lung cancer patients, and female patients have different clinicopathological characteristics co